National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 48938-48939 [2019-20030]
Download as PDF
<![CDATA[
48938
Federal Register / Vol. 84, No. 180 / Tuesday, September 17, 2019 / Notices
Announcement of Meeting of the
Secretary’s Advisory Committee on
National Health Promotion and Disease
Prevention Objectives for 2030
Department of Health and
Human Services, Office of the Secretary,
Office of the Assistant Secretary for
Health, Office of Disease Prevention and
Health Promotion.
ACTION: Notice.
AGENCY:
The U.S. Department of
Health and Human Services (HHS)
announces the next meeting of the
Secretary’s Advisory Committee on
National Health Promotion and Disease
Prevention Objectives for 2030
(Committee) regarding the development
of national health promotion and
disease prevention objectives for 2030.
The meeting will be held online via
webinar and is open to the public. The
Committee will discuss the nation’s
proposed health promotion and disease
prevention objectives and will provide
recommendations to improve health
status and reduce health risks for the
nation by the year 2030. The Committee
will discuss the role of data
partnerships and deliberate
recommendations for establishing data
partnerships for implementing and
achieving the Healthy People 2030
objectives. Pursuant to the Committee’s
charter, the Committee’s advice must
assist the Secretary in reducing the
number of objectives while ensuring
that the selection criteria identifies the
most critical public health issues that
are high-impact priorities supported by
current national data.
DATES: The Committee will meet on
October 2, 2019, from 11:00 a.m. to 1:00
p.m. Eastern Time (ET).
ADDRESSES: The meeting will be held
online via webinar. Registration for the
October 2, 2019 meeting will open on
September 16, 2019 at the Healthy
People website at https://
www.healthypeople.gov.
SUMMARY:
jbell on DSK3GLQ082PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Emmeline Ochiai, Designated Federal
Officer, Secretary’s Advisory Committee
on National Health Promotion and
Disease Prevention Objectives for 2030,
U.S. Department of Health and Human
Services, Office of the Assistant
Secretary for Health, Office of Disease
Prevention and Health Promotion, 1101
Wootton Parkway, Suite 420, Rockville,
MD 20852, (240) 453–8280 (telephone).
Additional information is available on
the Healthy People website at https://
www.healthypeople.gov.
VerDate Sep<11>2014
17:05 Sep 16, 2019
Jkt 247001
The
names and biographies of the
Committee members are available at
https://www.healthypeople.gov/2020/
about/history-development/healthypeople-2030-advisory-committee.
Purpose of Meeting: Through the
Healthy People initiative, HHS leverages
scientific insights and lessons from the
past decade, along with new knowledge
of current data, trends, and innovations,
to develop the next iteration of national
health promotion and disease
prevention objectives. Healthy People
provides science-based, 10-year national
objectives for promoting health and
preventing disease. Since 1979, Healthy
People has set and monitored national
health objectives that meet a broad
range of health needs, encourage
collaboration across sectors, guide
individuals toward making informed
health decisions, and measure the
impact of our prevention and health
promotion activities. Healthy People
2030 objectives will reflect assessments
of major risks to health and wellness,
changing public health priorities, and
emerging technologies related to our
nation’s health preparedness and
prevention. During the October 2, 2019
Committee meeting, the Committee will
discuss the role of data partnerships and
deliberate recommendations for
establishing data partnerships designed
to implement and achieve the Healthy
People 2030 objectives.
Public Participation at Meeting:
Members of the public are invited to
join the online Committee meeting.
There will be no opportunity for oral
public comments during the online
Committee meeting. Written comments
are welcome throughout the entire
development process of the national
health promotion and disease
prevention objectives for 2030 and may
be emailed to HP2030@hhs.gov.
To join the Committee meeting,
individuals must pre-register at the
Healthy People website at https://
www.healthypeople.gov. Participation in
the meeting is limited. Registrations will
be accepted until maximum webinar
capacity is reached. Registration for the
October 2, 2019 meeting must be
completed by 9:00 a.m. ET on October
2, 2019. A waiting list will be
maintained should registrations exceed
capacity, and individuals on the waiting
list will be contacted as additional space
for the meeting becomes available.
Registration questions may be directed
to HealthyPeople@norc.org.
Authority: 42 U.S.C. 300u and 42
U.S.C. 217a. The Secretary’s Advisory
Committee on National Health
Promotion and Disease Prevention
Objectives for 2030 is governed by
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
provisions of the Federal Advisory
Committee Act (FACA), Public Law 92–
463, as amended (5 U.S.C., App.) which
sets forth standards for the formation
and use of federal advisory committees.
Dated: September 5, 2019.
Donald Wright,
Deputy Assistant Secretary for Health,
Disease Prevention and Health Promotion.
[FR Doc. 2019–20095 Filed 9–16–19; 8:45 am]
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Digestive Diseases and
Nutrition C Subcommittee
Date: October 16–18, 2019.
Time: 6:00 p.m. to 10:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Maria E. Davila-Bloom,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 7017, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452,
(301)594–7637 davila-bloomm@
extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Diabetes,
Endocrinology and Metabolic Diseases B
Subcommittee.
Date: October 23–25, 2019.
Time: 5:30 p.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza National Airport, 1480
Crystal Drive, Arlington, VA 22202.
Contact Person: John F. Connaughton,
Ph.D., Chief, Scientific Review Branch
Review Branch, DEA, NIDDK, National
E:\FR\FM\17SEN1.SGM
17SEN1
Federal Register / Vol. 84, No. 180 / Tuesday, September 17, 2019 / Notices
Institutes of Health, Room 7007, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301)594–7797, connaughtonj@
extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Groupl; Kidney, Urologic and
Hematologic Diseases D Subcommittee
Date: October 29–31, 2019.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Capital View, 2850
South Potomac Avenue, Arlington, VA
22202.
Contact Person: Barbara A. Woynarowska,
Ph.D., Scientific Review Administrator,
Review Branch, DEA, NIDDK, National
Institutes of Health, Room 7007, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301)402–7172, woynarowskab@
niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: September 11, 2019.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–20030 Filed 9–16–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
jbell on DSK3GLQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; Conference Grants Review.
Date: November 6, 2019.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
17:05 Sep 16, 2019
Jkt 247001
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Jing Chen, Ph.D., Scientific
Review Officer, Office of Scientific Review,
National Center for Advancing Translational
Sciences (NCATS), National Institutes of
Health, 6701 Democracy Blvd., Democracy 1,
Room 1080, Bethesda, MD 20892–4874,
chenjing@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: September 11, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–20032 Filed 9–16–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Clinical
Neuroscience and Neurodegeneration.
Date: October 16, 2019.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Samuel C. Edwards, Ph.D.,
Chief, BDCN IRG, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 5210, MSC 7846,
Bethesda, MD 20892, (301) 435–1246,
edwardss@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Infectious,
Reproductive, Asthma and Pulmonary
Conditions.
Date: October 17, 2019.
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
48939
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lisa Steele, Ph.D.,
Scientific Review Officer, PSE IRG, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892, 301–594–
6594, steeleln@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Cancer Immunopathology and
Immunotherapy Study Section.
Date: October 21–22, 2019.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Dana on Mission Bay, 1710
West Mission Bay Drive, San Diego, CA
92109.
Contact Person: Denise R. Shaw, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158,
MSC 7804, Bethesda, MD 20892, 301–435–
0198, shawdeni@csr.nih.gov.
Name of Committee: Oncology 1-Basic
Translational Integrated Review Group;
Tumor Microenvironment Study Section.
Date: October 21–22, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel, 1700 Tysons
Boulevard, McLean, VA 22102.
Contact Person: Angela Y. Ng, MBA, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6200,
MSC 7804, Bethesda, MD 20892, 301–435–
1715, ngan@mail.nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Lung Injury, Repair, and Remodeling
Study Section.
Date: October 21–22, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites—Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Ghenima Dirami, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4122,
MSC 7814, Bethesda, MD 20892, 240–498–
7546, diramig@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Clinical Oncology Study Section.
Date: October 21, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel, 1700 Tysons
Boulevard, McLean, VA 22102.
Contact Person: Malaya Chatterjee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892, 301–806–
2515, chatterm@csr.nih.gov.
E:\FR\FM\17SEN1.SGM
17SEN1
]]>Agencies
[Federal Register Volume 84, Number 180 (Tuesday, September 17, 2019)]
[Notices]
[Pages 48938-48939]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-20030]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Initial Review Group; Digestive Diseases and
Nutrition C Subcommittee
Date: October 16-18, 2019.
Time: 6:00 p.m. to 10:00 a.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center,
Montgomery County Conference Center Facility, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Maria E. Davila-Bloom, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7017, 6707 Democracy Boulevard, Bethesda, MD 20892-5452,
(301)594-7637 [email protected].
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Initial Review Group; Diabetes, Endocrinology
and Metabolic Diseases B Subcommittee.
Date: October 23-25, 2019.
Time: 5:30 p.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Crowne Plaza National Airport, 1480 Crystal Drive,
Arlington, VA 22202.
Contact Person: John F. Connaughton, Ph.D., Chief, Scientific
Review Branch Review Branch, DEA, NIDDK, National
[[Page 48939]]
Institutes of Health, Room 7007, 6707 Democracy Boulevard, Bethesda,
MD 20892-5452, (301)594-7797, [email protected].
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Initial Review Groupl; Kidney, Urologic and
Hematologic Diseases D Subcommittee
Date: October 29-31, 2019.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Capital View, 2850 South Potomac Avenue,
Arlington, VA 22202.
Contact Person: Barbara A. Woynarowska, Ph.D., Scientific Review
Administrator, Review Branch, DEA, NIDDK, National Institutes of
Health, Room 7007, 6707 Democracy Boulevard, Bethesda, MD 20892-
5452, (301)402-7172, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: September 11, 2019.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-20030 Filed 9-16-19; 8:45 am]
BILLING CODE 4140-01-P
